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The resurgence of invasive disease caused by Streptococcus pyogenes (group A Streptococcus [GAS]) in the past 30 years has par-
alleled the emergence and global dissemination of the highly virulent M1T1 clone. The GASM1T1 clone has diverged from the
ancestral M1 serotype by horizontal acquisition of two unique bacteriophages, encoding the potent DNase Sda1/SdaD2 and the
superantigen SpeA, respectively. The phage-encoded DNase promotes escape from neutrophil extracellular traps and is linked to
enhanced virulence of the M1T1 clone. In this study, we successfully used in vitro lysogenic conversion to transfer the Sda1-en-
coding phage from theM1T1 clonal strain 5448 to the nonclonal M1 isolate SF370 and determined the impact of this horizontal
gene transfer event on virulence. Although Sda1 was expressed in SF370 lysogens, no capacity of the phage-converted strain to
survive human neutrophil killing, switch to a hyperinvasive covRSmutant form, or cause invasive lethal infection in a human-
ized plasminogenmouse model was observed. This work suggests that the hypervirulence of the M1T1 clone is due to the unique
synergic effect of the M1T1 clone bacteriophage-specific virulence factor Sda1 acting in concert with theM1T1 clone-specific
genetic scaffold.
Streptococcus pyogenes (groupA Streptococcus [GAS]) is a strictlyhuman pathogen, able to colonize the skin and throat asymp-
tomatically or to triggermild, localized superficial infections, such
as impetigo and pharyngitis. Less frequently, GAS invades nor-
mally sterile body sites to cause systemic, severe, and often life-
threatening pathologies, including necrotizing fasciitis and toxic
shock syndrome. The virulencemechanisms that confer this inva-
sive capacity onGAS, allowing evasion of the host immune system
and penetration of deeper tissues, are complex and only partially
elucidated (1, 2, 3). Although disease incidence decreased mark-
edly in the first part of the 20th century, the past 3 decades have
witnessed a resurgence in invasive GAS pathologies (4–7). A non-
random association between invasive disease and a number of
GAS serotypes (M1, M3, M18, M28) has been reported, linked
particularly to the emergence of highly virulent subtypes, such as
the globally disseminated M1T1 clone (3, 7, 8), defined here as
GAS M1T1 strains containing the bacteriophage-encoded viru-
lence factors Sda1 and SpeA (5, 9, 10).
The diversification of GAS serotypes has been attributed to
molecular and genetic variations often related to the acquisition of
phage-associated virulence factors (7, 9, 11–13). Comparative
genomic analysis of the M1T1 clonal isolate MGAS5005 (14) and
the nonclonal M1 isolate SF370 (15) identified the main differ-
ences between these two GAS types as the carriage of different
prophages containing specific toxins (SpeC, MF2, and SpeI/SpeH
within SF370; SpeA and Sda1 within MGAS5005) and the pres-
ence in MGAS5005 of an M12-derived 36-kb genomic recom-
bination region that is absent in SF370 (6, 14, 16). The evolu-
tionary steps that have led to the emergence of the
hypervirulent M1T1 clone have been elucidated recently and
confirm the major role played by horizontal gene transfer mech-
anisms, which include unique prophage acquisition events, in the
epidemiology of GAS (17).
Much research has focused on determining the impact of indi-
vidual virulence determinants on the M1T1 clone virulence phe-
notype through “loss-of-function” gene knockout studies. Sda1,
encoded on an M1T1 prophage, is a potent streptococcal DNase
(18). Targeted mutagenesis of the sda1 gene sensitizes GAS to
killing within DNA-based neutrophil extracellular traps (NETs)
(19). For GAS M1T1, the onset of invasive disease is associated
with an in vivo switch to a SpeB-negative phenotype, where the
expression of the broad-spectrum cysteine protease SpeB is abol-
ished as a consequence of point mutations in the two-gene regu-
latory sensor kinase operon covRS (2, 20). The transcriptional shift
that results in the loss of SpeB and increased expression of Sda1
and other streptococcal virulence factors triggers systemic infec-
tion (1). In turn, it has been shown by gene knockout studies that
Sda1 expression provides selective pressure for the switch to the
hypervirulent covRS mutant M1T1 genotype (1). Other gene
products that also contribute to this selective pressure include the
virulence determinants M1 protein and the hyaluronic acid cap-
sule (21).
In this study, we investigated the impact of Sda1-encoding
phage carriage on virulence and invasive disease propensity by a
“gain-of-function” approach, via lysogenic conversion of the
M1 GAS strain SF370 with theM1T1 Sda1-encoding phage. We
demonstrate that the enhanced virulence of the M1T1 clone
results from the unique combination of the bacteriophage-spe-
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cific virulence factor Sda1 with the M1T1 clone-specific genetic
backbone.
MATERIALS AND METHODS
Comparative bioinformatic analysis of M1 SF370 andM1T1 5448 GAS
sequences. Whole-genome sequencing of the M1T1 strain 5448, a strain
representative of the globally disseminated M1T1 clone encoding the
DNase Sda1 (16), was carried out using the Illumina (San Diego, CA)
HiSeq 2000 system as described previously (17) and yielded a total of
8,879,651 paired-end 100-bp reads, corresponding to an estimated cover-
age of 987.Denovo assemblywas performed usingVelvet, version 1.1.05
(22), to produce a draft genome sequence composed of 36 scaffolds for a
total of 1,800,853 assembled bases. To optimize the assembly process
(which tends to counterperform with very high read coverage) and
achieve optimal performance, the data set was sampled down to 1million
read pairs for an estimated 100 coverage assembly. The genome of the
M1T1 strain MGAS5005 (RefSeq accession no. NC_007297) (14) was
then used as a reference for reordering the 36 scaffolds of strain 5448,
using ABACAS (23), and for transferring annotation, using RATT (24).
To investigate variations in its genetic structure, the draft genome se-
quence of the M1T1 strain 5448 was compared with the completed ge-
nome sequences of MGAS5005 and the GAS M1 strain SF370 (RefSeq
accession no. NC_002737) (15) by using Easyfig (25). Reads were depos-
ited in the Sequence Read Archive (SRA) (http://www.ncbi.nlm.nih.gov
/sra). The SRA sample accession number is ERS123209.
GAS strains and culture. The GAS isolates used in this study are
SF370-Smr, a spontaneous streptomycin-resistant (Smr) mutant of the
sequenced M1 isolate SF370 (15), obtained by subculturing on selective
Todd-Hewitt (Difco Laboratories) agar supplemented with 1% (wt/vol)
yeast extract (THY agar) and 150 g/ml streptomycin; GAS strain 5448
(see above); and 5448sda-Cmr, an isogenic mutant of 5448 in which the
sda1 gene has been replaced with a chloramphenicol resistance (Cmr)
marker (19). Bacterial strains were routinely cultured on solid commer-
cial horse blood agar (bioMérieux, Australia) or in Todd-Hewitt broth
(Difco Laboratories) supplemented with 1% (wt/vol) yeast extract (THY
broth) at 37°C without shaking.
In vitro lysogenic conversion of GAS SF370-Smr. GAS 5448sda-
Cmr was used as the phage donor strain, and SF370-Smr was used as the
phage recipient strain. Briefly, overnight bacterial cultures were diluted
1:20 in prewarmed THY broth and were grown statically to an A600 of
0.25. The 5448sda-Cmr culture was treated with mitomycin C (0.2 mg/
ml) and was grown statically for 3 h at 37°C. In order to determine suc-
cessful phage induction, a 5-ml aliquot of this induced culture was re-
tained for the detection of phage DNA in the culture supernatant. Phage
DNA was purified as described previously (26). Briefly, a filter-sterilized
supernatant was used for phage DNA isolation via Benzonase treatment
(Novagen, USA) to eliminate genomic DNA contamination, followed by
phage extraction using phenol-chloroform-isoamyl alcohol (25:24:1)
(Sigma-Aldrich) and ethanol precipitation of DNA. Phage induction was
verified by PCR amplification of specificM1T1 phage-encoded toxins (see
Table S1 in the supplemental material). Lysogeny was performed by the
addition of 100 l of induced 5448sda-Cmr culture to 900 l of unin-
duced SF370-Smr recipient culture, followed by static incubation at 37°C
for a further 3 h. This mixed culture was used to inoculate selective THY
broth (Cm, 2 g/ml; Sm, 150 g/ml) at a 1:10 dilution, and the mixture
was then incubated statically at 37°C for 48 h for the selection and ampli-
fication of lysogenized bacteria. Culture aliquots were plated onto selec-
tive THY agar (Cm, 2 g/ml; Sm, 150 g/ml) and were incubated over-
night at 37°C. Single colonies grown with double selection were tested by
PCR for the presence ofM1T1-specific andM1-specific gene sequences. A
single Smr Cmr colony was selected and was designated SF370-
Smr(5448.3 Cmr).
Allelic replacement to reconstruct the Sda1-encoding phage in the
SF370 background. Allelic exchange was used to replace the chloram-
phenicol resistance gene in SF370-Smr(5448.3 Cmr) with the wild-type
sda1 gene from 5448. The methodology followed was that described pre-
viously (1). Briefly, the temperature-sensitive pHY304-sda vector (pSda)
carrying the 5448 sda1 gene and an erythromycin resistance marker was
employed. For selection of the plasmid, erythromycin was used at a con-
centration of 2 g/ml in GAS and 500 g/ml in Escherichia coli, and
bacteria were cultured at 30°C. Plasmid pSda was introduced into SF370-
Smr(5448.3 Cmr) by electroporation (27), and chromosomal integra-
tion was achieved by double crossover after the removal of selective
antibiotics as described previously (28), resulting in GAS strain SF370-
Smr(5448.3 Sda).
Lysogen characterization. PCR amplification and Sanger DNA se-
quencing were used to confirm the identities of the SF370-Smr lysogens
and to determine phage and sda1 gene insertion sites in order to exclude
the occurrence of deletion events or other gene alterations during lysog-
eny. Genomic DNA was isolated from overnight liquid cultures by using
the DNeasy blood and tissue kit (Qiagen, CA, USA) according to the
manufacturer’s instructions. The primers and cycling conditions used for
PCR screening are listed in Table S1 in the supplemental material. The
hyaluronic acid capsule content in GAS cultures at an A600 of 0.4 was
determined by the Stains-All method as described previously (29). Both
SpeB in stationary-phase (overnight) supernatants and SpeC and Sda1 in
mid-logarithmic-phase (A600, 0.4) supernatantswere detected byWestern
blotting using standard protocols (30).
DNase activity andneutrophil resistance.DNase activity was assayed
essentially as described previously (18). Briefly, calf thymusDNA (Sigma)
FIG 1 Comparison of the GAS SF370 and M1T1 genomes. The linear diagrams show pairwise comparisons between the draft genome sequence of GAS
M1T1 strain 5448 (top) and the complete genome sequences of the GAS M1T1 reference strain MGAS5005 (RefSeq accession no. NC_007297) and GAS
M1 strain SF370 (RefSeq accession no. NC_002737). In each genome, prophages are shown as red (M1T1) or green (M1) boxes. Insertion sequences and
ribosomal operons in MGAS5005 are shown as orange triangles and black boxes, respectively. The M12-derived 36-kb recombination region is indicated
by gray boxes labeledM12. The colored blocks between each genome represent regions of conserved syntenic gene content, ranging in pairwise nucleotide
identity (according to BLASTn) from 100% (dark blue) to 99% (yellow). The diagrams were prepared using the Easyfig genome comparison visualization
tool (25).
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was incubated at 37°C with 2.5 l of GAS supernatant (A600, 0.4) in acti-
vation buffer (1 mM CaCl2, 1 mM MgCl2, and 100 mM Tris buffer [pH
7.6]). A sample consisting of THY broth only was included in the exper-
iment as a negative control. After 5 min, EDTA was added to a final
concentration of 66 mM to stop the reaction. The reaction products were
then loaded onto a 1.0% (wt/vol) agarose gel and were stained with
ethidium bromide for DNA visualization. GAS survival following incuba-
tion with human neutrophils in vitro was assayed as described previously
FIG2 Genetic characterization of SF370-Smr lysogens. (a) PCR amplification ofGAS virulence genes speB, speC, speA, and sda1. Lanes 1, 5448; lanes 2, 5448sda;
lanes 3, SF370-Smr; lanes 4, SF370-Smr(5448.3 Cmr); lanes 5, SF370-Smr(5448.3 Sda). (b) Schematic illustrating the M1T1 5448.3 phage insertion site
within the M1 SF370 genome backbone. In SF370-Smr(5448.3 Cmr), the chloramphenicol resistance gene replaces the sda1 open reading frame of phage
5448.3. The red line indicates the phage insertion point immediately adjacent to a tRNA-Ser sequence. (c) Alignment of the Sda1-encoding bacteriophage
attachment sites in wild-type M1T1 strains (MGAS5005 and 5448) and M1 lysogens SF370-Smr(5448.3 Cmr) and SF370-Smr(5448.3 Sda). The sequences
of the wild-type strains and the lysogens are identical. Phage insertion causes duplication of the sequence at the insertion point, resulting in a set of direct repeats
(boldface). Brackets indicate the boundaries of open reading frames. The highlighted sequences represent the first (blue) and last (green) open reading frames of
phages5005.3 and 5448.3. (d) Alignment of the insertion site of the sda1 gene within the Sda1-encoding bacteriophage in wild-typeM1T1 strains (MGAS5005
and 5448) and theM1 lysogen SF370-Smr(5448.3 Sda). The sequences are identical. sda1 insertion by double crossover has occurredwithout disruption of the
sda1 open reading frame or of the 5= sequence containing the promoter region (the35 box is framed in red and the10 box in blue). The starting codon for
the sda1 gene is shown in boldface, and the sda1 open reading frame is underlined.
Venturini et al.
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(1, 31). Experiments were performed in biological triplicate using mid-
logarithmic-phase (A600, 0.4) GAS at a multiplicity of infection (MOI) of
10:1 (GAS to neutrophils).
Visualization and quantification of NETs.NETs were visualized and
quantified as described previously (21).
In vivo SpeB-switching assays and virulence. To determine the rate
of switching to a SpeB-negative phenotype in vivo, C57BL/J6 mice were
challenged subcutaneously with Gas at 1  107 CFU/dose, and SpeB-
switching assays were undertaken as described previously (1, 31). Amod-
ified azocaseinolytic assay (32) and culturing onColumbia skimmilk agar
(33) were used to assess the expression of SpeB cysteine protease. To
determine the virulence potential of SF370-Smr lysogens, the humanized
plasminogen transgenic AlbPLG1mouse model (34) was used for subcu-
taneous GAS infection as described previously (1, 17, 28, 30, 31).
RESULTS
Comparative genomic analysis ofGAS strains 5448,MGAS5005,
and SF370. A de novo-assembled draft genome of M1T1 strain
5448 (17) was used here for comparative analysis with the com-
pleted genome sequences of theM1T1 strainMGAS5005 (14) and
the M1 strain SF370 (15) to confirm and visualize the nature and
position of genetic differences (Fig. 1). M1T1 strains MGAS5005
and 5488 are virtually identical across their entire lengths, with no
detectable sequence variation in the DNase Sda1 prophages that
promote GAS virulence and invasive disease capacity (5005.3
and 5448.3, respectively) (1). Most of the observed disruptions
of synteny between MGAS5005 and strain 5488 were caused by
gaps in the draft assembly due to repeat regions, such as insertion
sequences and ribosomal operons (Fig. 1). Alignment of the three
genomes confirms that the main differences between SF370
and M1T1 GAS are attributable to the presence of distinct ex-
ogenous genetic elements. These comparative analyses high-
light the role of bacteriophages in GAS genetic diversity as
reported previously (9, 14).
Characterization of SF370-Smr lysogens. In vitro lysogenic
conversion of SF370-Smr to SF370-Smr(5448.3 Cmr) was fol-
lowed by allelic replacement of the chloramphenicol resistance
marker with the 5448 sda1 gene to produce SF370-Smr(5448.3
Sda). To characterize the lysogens produced by these experimen-
tal procedures, the virulence genes speC (370.1; strain SF370),
speA (5448.1; strain 5448), and sda1 (5448.3; strain 5448), and
the ubiquitous chromosomally located gene speB, were amplified
by PCR (Fig. 2a). As expected, all GAS strains were speB positive;
5448 was positive for speA; and SF370 isogenic isolates were pos-
itive for speC. Lysogens SF370-Smr(5448.3 Sda) and 5448 were
positive for sda1 (Fig. 2a). The 5448.3 phage attachment sites
and the sda1 reinsertion boundaries were also PCR amplified and
sequenced to confirm that phage and sda1 insertion had occurred
in SF370-Smr(5448.3 Sda) in the same genetic location as in
GASM1T1 strains (MGAS5005 and 5448) (Fig. 2b). Comparative
sequence analysis showed that insertion of 5448.3 and of the
sda1 gene had not caused any deletions or duplications in the
SF370-Smr nucleotide sequence (Fig. 2c and d). Superantigen and
Sda1 DNase expression was examined in culture supernatants.
The Western blot data correlated with the PCR screening results,
with all isolates expressing SpeB in stationary-phase culture super-
natants (Fig. 3a) and only SF370 isogenic isolates expressing SpeC
(Fig. 3b). SF370-Smr(5448.3 Sda) also expressed Sda1 in mid-
log-phase culture supernatants, albeit at levels lower than those in
the M1T1 isolate 5448 (Fig. 3c). Confirming previous studies (35,
36), SpeA expression was undetectable in supernatants of in vitro-
grownGAS (data not shown).Hyaluronic acid capsule assayswere
performed on SF370-Smr, SF370-Smr(5448.3 Cmr), and SF370-
Smr(5448.3 Sda), andno significant difference in capsule produc-
tionbetween thewild type and the lysogenswasdetected (Fig. 3d).All
SF370 derivatives expressed higher capsule levels than the M1T1
strain 5448, in agreement with previous studies (17).
Resistance of GAS lysogens to killing by human neutrophils.
DNase activity was determined by coincubation of GAS culture
supernatants with calf thymus DNA. The levels of DNA degrada-
tion by SF370-Smr(5448.3 Sda) were greater than those for
SF370-Smr and SF370-Smr(5448.3 Cmr) and were comparable
to that for theM1T1 strain 5448 (Fig. 4a). Since neutrophil killing
via DNA NETs plays a central role in bacterial clearance during
GAS infection, and since Sda1 has been directly linked to NET
degradation (19), we compared both the capacity to clear NETs
and the degree of survival of SF370-Smr lysogens with that of
wild-type SF370-Smr and theM1T1 strain 5448when these strains
were coincubated with human neutrophils. Even though a signif-
icant increase in the ability to degrade DNANETs, comparable to
that of M1T1 strain 5448, was observed for SF370-Smr(5448.3
Sda) (Fig. 4b and c), this lysogenized strain did not show in-
creased resistance to killing by neutrophils (Fig. 4d).
Invasive capacity and virulence of GAS lysogens. Carriage of
the sda1 gene has been characterized as a necessary selection trig-
ger for the in vivo phase switch of GAS M1T1 to a hypervirulent
FIG 3 Expression of virulence proteins and the hyaluronic acid capsule. (a)
SpeB production was detected in stationary-phase culture supernatants.
Lanes: 1, 5448; 2, SF370-Smr; 3, SF370-Smr(5448.3 Cmr); 4, SF370-
Smr(5448.3 Sda). (b) SpeC expression in mid-log-phase (A600, 0.4) culture
supernatants. All lysogens expressed both SpeB and SpeC, as expected. (c) Sda1
expression in mid-log-phase (A600, 0.4) culture supernatants. (d) Hyaluronic
acid capsule production was examined using the Stains-All method (29). The
three M1 strains SF370-Smr, SF370-Smr(5448.3 Cmr), and SF370-
Smr(5448.3 Sda) produced comparable amounts of hyaluronic acid cap-
sule, greater than the amount produced by theM1T1 strain 5448. Bars indicate
means; error bars, standard deviations (n 3).
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phenotype (1, 17).We therefore tested the SF370-Smr lysogenized
strains for a propensity to switch to the hypervirulent covRSmu-
tant form. There was no evidence of an increased capacity to
switch to the SpeB-negative hypervirulent form for any of the
three SF370 derivatives characterized in this study (Fig. 5a). In
order to examine virulence potential, AlbPLG1 mice were infected
subcutaneously with GAS strains 5448, SF370-Smr, SF370-
Smr(5448.3Cmr), and SF370-Smr(5448.3 Sda). SF370 is known
tobe avirulent in thismousemodel (17),while theM1T1 isolate 5448
was hypervirulent (1, 17), with only 20% of the infected mice (at a
dose of 1.3 107 CFU) surviving by day 7 (Fig. 5b). At comparable
infection doses, SF370-Smr, SF370-Smr(5448.3 Cmr), and SF370-
Smr(5448.3 Sda) were avirulent (Fig. 5b).
DISCUSSION
The resurgence of GAS invasive disease in the past 30 years has
coincided with the emergence and global dissemination of the
hypervirulent M1T1 clone. The M1T1 serotype evolved from the
ancestralM1 lineage via sequential horizontal gene transfer events,
involving homologous recombination and prophage transduction,
that led to the stable acquisition of two unique virulence determi-
nants, the superantigen SpeA and the streptodornase Sda1, and in-
creased expression of the extracellular toxins NAD-glycohydrolase
(Nga) and streptolysin O (SLO) (2, 14, 17). Our sequencing efforts
confirmed the accumulation of the majority of the M1T1 serotype-
specific single nucleotide polymorphisms (SNPs), in comparison to
SF370,within these acquired regions (14). In theGASM1T1genome,
the prophage encoding sda1 contains all the modules necessary for
transfer and lysogeny, promotes invasive disease (1, 17), and there-
fore is potentially readily mobilizable to other GAS strains under ap-
propriate conditions. In this study, we set out to determine whether
the acquisition of this sda1-encoding phage was sufficient to confer
enhanced virulence in a non-M1T1 GAS background.
The induced sda1-encoding phage was transferred by a combi-
FIG 4 Sda1 activities and resistance to neutrophil killing of lysogenized SF370 isolates. (a) DNase activities of stationary-phase GAS culture supernatants were
determined by coincubation with calf thymus DNA. Lane 1, calf thymus DNA only (negative control); lane 2, 5448; lane 3, 5448sda; lane 4, SF370-Smr; lane 5,
SF370-Smr(5448.3 Cmr); lane 6, SF370-Smr(5448.3 Sda). Only 5448 and SF370-Smr(5448.3 Sda) supernatants, containing Sda1, degraded DNA. (b) The bar
graph shows the quantification of DNANET induction per field of view after exposure to Sytox orange in wild-type GASM1T1 (5448) and GASM1 (SF370-Smr) and
in the lysogens SF370-Smr(5448.3 Cmr) and SF370-Smr(5448.3 Sda). In SF370-Smr(5448.3 Sda), NET clearancewas significantly greater than that forM1GAS
strains SF370-Smr and SF370-Smr(5448.3Cmr) (P,0.0007 for both comparisons) and comparable to that for thewild-type strain 5448. Values are arithmeticmeans
plus standard errors (error bars) and are representative of three independent experiments performed in triplicate. Statistical 1-way analysis of variance with Dunnett’s
multiple-comparison posttest (P, 0.05) was performed using GraphPad Prism software. (c) Visualization of Sytox orange-stained DNA NETs (red) induced by
coincubationofGAS serotypeM1T1 strain 5448,M1 strain SF370-Smr, SF370-Smr(5448.3Cmr), andSF370-Smr(5448.3 Sda)withhumanneutrophils (MOI, 0.1).
Fewer NETs can be observed for the SF370-Smr(5448.3 Sda) lysogen, expressing Sda1, than for strains SF370-Smr and SF370-Smr(5448.3 Cmr). (d) Percentage of
survival following coculturewith humanneutrophils in vitro. No significant differencewas observed between the SF370-Smr parent strain and the lysogens, all of which
were less neutrophil resistant than theM1T1 strain 5448 (P,0.0008). Bars indicatemeans; error bars, standard deviations (n 3). Statistical 1-way analysis of variance
with Bonferroni’s multiple-comparison posttest (P,0.05) was performed using GraphPad Prism software.
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nation of lysogeny and allelic replacement into the M1 strain
SF370 background. Previous studies using the knockout strain
5448sda showed that in M1T1 strains, the Sda1 DNase plays an
essential role in the clearance of NETs and is necessary for the
switch to the hyperinvasive SpeB-negative covRSmutant form (1,
19). In our study, the SF370-Smr(5448.3 Sda) lysogen, which
expresses functionalDNase Sda1, failed to display either enhanced
resistance to neutrophil killing, a capacity to switch to a hyperin-
vasive phenotype, or increased virulence. Themoderate difference
in levels of Sda1 expression between the M1 and M1T1 strains
observed in this study may be due to differing regulation of sda1
gene expression. The M1 and M1T1 genomes differ by a num-
ber of SNPs that affect regulators and modify the expression of
a selected number of genes, including the has operon, slo, and
nga (17, 21).
The killing ofmicrobes by neutrophils is amultifaceted process
involving DNA NETs as well as phagocytosis and the release of
proteolytic enzymes, cationic antimicrobial peptides, and reactive
oxygen and nitrogen species (37, 38). The evasive response of GAS
is in turn complex and requires the combined action of several
virulence factors (2). Protection against killing by human neutro-
phils is achieved not only via the production of DNases, such as
Sda1 (19), but also via the inhibitory activity of the M1 protein
(39) and the hyaluronic acid capsule (21) against the antimi-
crobial peptides embedded in NETs, as well as the activities of
the streptococcal complement inhibitor protein (40) and
streptolysin S (41).
Through the use of knockout strains, it was demonstrated pre-
viously that the presence of Sda1, M1, and the hyaluronic acid
capsule is essential for induction of the switch to a SpeB-negative
phenotype (1, 21). The proposedmodel for invasive disease devel-
opment sees the degradation of NETs by the Sda1 DNase as the
trigger for this phenotype switch in a subpopulation ofM1T1 cells
due to spontaneous mutations in the covRS regulatory operon,
causing the upregulation of several virulence factors (the Sda1
DNase, the immunogenic M1 protein, the HasA hyaluronic acid
capsule, the endopeptidase IdeS, the cytolysin SLO, and the pro-
tease SPyCEP) and the downregulation of the cysteine protease
SpeB (2). This transcriptional shift promotes subversion of the
human plasminogen activation system and systemic dissemina-
tion to sterile sites of the body (1, 30).
In invasive M1T1 isolates, SLO and Nga expression is higher
than that in the ancestral strain SF370. Increased SLO and Nga
expression is due to the presence of the M12-derived 36-kb re-
combination fragment found in the M1T1 clone (14, 17). Utiliz-
ing M1T1 slo and nga deletion mutants, Cole et al. showed that
these factors do not contribute directly to SpeB switching and
selection pressure for increased virulence in a mouse model (21).
SLO nonetheless remains an important virulence factor impli-
cated in GAS virulence and the clearance of immune system com-
ponents at the site of infection (2, 42). In ancestral GAS M1
strains, such as SF370, hyaluronic acid capsule expression is higher
than that of M1T1 strains (17). Capsule expression also contrib-
utes to SpeB switching and virulence (21), and thus, differing lev-
els of capsule expression in SF370 may also potentially reduce
selection for covRS mutants in vivo. The SpeA superantigen is
absent in the ancestral GAS M1 strain SF370 (14). SpeA was first
associated with severe cases of streptococcal shock syndrome in
the late 1980s (4, 5). Recent gene knockout studies indicate that
SpeA is not directly involved in the mechanism of invasive disease
initiation, but its acquisition may aid in defense against the host
immune system and the subsequent dissemination of the hyper-
virulent M1T1 clone (17).
Given that a combination of GAS virulence factors promotes
neutrophil resistance, it is perhaps not surprising that the intro-
duction of the single gene sda1 into the SF370 background did not
enhance neutrophil resistance and virulence, despite improved
clearance of DNA NETs. Our experimental observations may be
explained by a requirement for a cohort of virulence determinants
expressed at a specific level to promote virulence, including Sda1,
the M1 protein, the hyaluronic acid capsule, and SLO (21, 42). In
this context, it is pertinent to this hypothesis that SF370 expresses
much higher levels of the hyaluronic acid capsule thanGASM1T1
strains (17), which may tip the balance away from the selection of
covRSmutants in the presence of neutrophils, resulting in failure
to promote selection for the hyperinvasive phenotype.
We conclude that the hypervirulence of the M1T1 clone is due
to the synergic effect of the M1T1 clone bacteriophage-specific
FIG 5 Characterization of SF370-Smr lysogen virulence. (a) Percentage of SpeB-positive isolates that switch to a SpeB-negative phenotype following a 3-day
subcutaneous passage in C57BL/J6 mice. Each data point represents a single infected mouse (n, 10 mice per strain). (b) Percentage of survival of humanized
plasminogen transgenic mice after subcutaneous infection with SF370-Smr (1.6  107 CFU/dose), SF370-Smr(5448.3 Cmr) (1.2  107 CFU/dose), SF370-
Smr(5448.3 Sda) (1.1 107 CFU/dose), and 5448 (1.3 107 CFU/dose). While 5448 infection caused the death of 80% of the mice, all SF370 strains were
avirulent when an equivalent infection dose was used. Comparative analysis of survival curves (Mantel-Cox test) was performed usingGraphPad Prism software.
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virulence factor Sda1 acting in concert with the M1T1 clone-spe-
cific genetic scaffold. This work suggests that the emergence of
hypervirulent GAS clones is dependent on a fine balance of viru-
lence determinants acting in unison.
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